Trump had promised in March 2016, to reform the pharmaceutical industry, including the removal of existing free market barriers to allow imported, dependable, safe, reliable, and cheaper drugs from overseas, bringing more options to American consumers.[463] Following Trump's press conference on January 11, Fortune claimed that the largest pharmaceutical companies had lost over $20 billion in 20 minutes.[464] The Medicare Prescription Drug, Improvement, and Modernization Act (2003) expressly prohibited Medicare from negotiating bulk prescription drug prices and Trump had pledged to revert this. Following the morning meeting with CEOs on January 31, Trump abandoned his pledge to allow "Medicare negotiate bulk discounts in the price it pays for prescription drugs."[465]